Variable inhibitory effect of different brands of commercial herbal supplements on human cytochrome P-450 CYP3A4

Drug Metabolism and Drug Interactions

Volumn 24, Issue 1, 2009, Pages 17-35

  Wanwimolruk, Sompon ^a   Wong, Keldon ^a   Wanwimolruk, Preeya ^a  

^a LOMA LINDA UNIVERSITY   (United States)

Author keywords

Black cohosh; CYP3A4; Dietary supplements; Drug interactions; Ginseng; Grape seed extract; Green tea

Indexed keywords

ACTION LABS; CIMICIFUGA RACEMOSA EXTRACT; COUNTRY LIFE; CYTOCHROME P450 3A4; GINSENG EXTRACT; GNC; GNC HERBAL PLUS; GNC NATURES FINGERPRINTS; GRAPE SEED EXTRACT; GREEN TEA EXTRACT; HENRYS FARMERS MARKET; IMPERIAL ELIXIR; JARROW FORMULAS; LIFE TIME; LOMA LINDA MARKET; METHANOL; MRM; NATROL; NATURAL FACTORS; NATURES RESOURCE; NATURES WAY; PARADISE HERBS; QUININE; REXALL; ROOT TO HEALTH; SOLARAY; SPRING VALLEY; SUNDOWN; UNCLASSIFIED DRUG; VEGLIFE; WALGREENS FINEST NATURAL;

ADULT; ARTICLE; CONCENTRATION RESPONSE; CONTROLLED STUDY; DIET SUPPLEMENTATION; DRUG EFFICACY; DRUG LEGISLATION; DRUG SAFETY; ENZYME INHIBITION; HERB DRUG INTERACTION; HIGH PERFORMANCE LIQUID CHROMATOGRAPHY; HUMAN; HUMAN TISSUE; IN VITRO STUDY; INCUBATION TIME; LIVER MICROSOME; MALE; PRESCRIPTION;

EID: 63449126034     PISSN: 07925077     EISSN: None     Source Type: Journal    
DOI: 10.1515/DMDI.2009.24.1.17     Document Type: Article

References (49)

1. Pierce JP, Faerber S, Wright FA, et al. A randomized trial of the effect of plant-based dietary pattern on additional breast cancer events and survival: the Women's Healthy Eating and Living (WHEL) study. Control Clin Trials 2002; 23: 728-756.
2. Richardson MA, Ramirez T, Palmer JL, Greisinger A, Singletary SE. Complementary/alternative medicine use in a comprehensive cancer center and the implications for oncology. J Clin Oncol 2000; 18: 2505-2514.
3. Rock CL. Antioxidant supplement use in cancer survivors and the general population. In: Free Radicals: The Pros and Cons of Antioxidants. Bethesda, MD: NIH, 2003.
4. Wargovich MJ, Woods C, Hollis DM, Zander ME. Herbals, cancer prevention and health. J Nutr 2001; 131: 3034S-3036S.
5. Wargovich MJ. Colon cancer chemoprevention with ginseng and other botanicals. J Korean Med Sci 2001; 16 (Suppl): S81-S86.
6. Wargovich MJ. Diallyl sulfide, a flavor component of garlic (Allium sativum), inhibits dimethylhydrazine-induced colon cancer. Carcinogenesis 1987; 8: 487-489.
7. Wargovich MJ, Woods CJ, Eng VW, Stephens LC, Gray K. Chemoprevention of N-nitrosomethylbenzylamine-induced esophageal cancer in rats by the naturally occurring thiother, diallyl sulfide. Cancer Res 1988; 48: 6872-6875.
8. Hasler JA. Pharmacogenetics of cytochromes P450. Mol Aspects Med 1999; 20: 12-24, 25-137.
9. Nelson DR, Koymans L, Kamataki T, et al. P450 superfamily: update on new sequences, gene mapping, accession numbers and nomenclature. Pharmacogenetics 1996; 6: 1-42.
10. Nebert DW, Russell DW. Clinical importance of the cytochromes P450. Lancet 2002; 360: 1155-1162.
11. Guengerich FP. Cytochrome P450 3A4: regulation and role in drug metabolism. Annu Rev Pharmacol Toxicol 1999; 39: 1-17.
12. Huang Z, Fasco MJ, Figge HL, et al. Expression of cytochromes P450 in human breast tissue and tumors. Drug Metab Dispos 1996; 24: 899-905.
13. Kolars JC, Lown KS, Schmiedlin-Ren P, et al. CYP3A gene expression in human gut epithelium. Pharmacogenetics 1994; 4: 247-259.
14. Lown KS, Bailey DG, Fontana RJ, et al. Grapefruit juice increases felodipine oral availability in humans by decreasing intestinal CYP3A protein expression. J Clin Invest 1997; 99: 2545-2553.
15. Shimada T, Yamazaki H, Mimura M, et al. Interindividual variations in human liver cytochrome P-450 enzymes involved in the oxidation of drugs, carcinogens and toxic chemicals: studies with liver microsomes of 30 Japanese and 30 Caucasians. J Pharmacol Exp Ther 1994; 270: 414-423.
16. Watkins PB, Wrighton SA, Schuetz EG, et al. Identification of glucocorticoid-inducible cytochromes P-450 in the intestinal mucosa of rats and man. J Clin Invest 1987; 80: 1029-1036.
17. Rockwell S, Liu Y, Higgin SA. Alteration of the effects of cancer therapy agents on breast cancer cells by the herbal medicine black cohosh. Breast Cancer Res Treat 2005; 90: 233-239.
18. Sparreboom A, Cox MC, Acharya MR. Figg WD. Herbal remedies in the United States: potential adverse reactions with anticancer drugs. J Clin Oncol 2004; 22: 2489-2503.
19. Agarwal C, Singh RP, Agarwal R. Grape seed extract induces apoptotic death of human prostate carcinoma DU145 cells via caspases activation accompanied by dissipation of mitochondrial membrane potential and cytochrome c reductase. Carcinogenesis 2002; 23: 1869-1876.
20. Chen D, Daniel KG, Chen MS, Kuhn DJ, Landis-Piwowar KR, Dou QP. Dietary flavonoids as proteasome inhibitors and apoptosis inducers in human leukemia cells. Biochem Pharmacol 2005; 69: 1421-1432.
21. Singletary KW, Meline B. Effect of grape seed proanthocyanidins in colon aberrant crypts and breast tumors in a rat dual-organ tumor model. Nutr Cancer 2001; 39: 252-258.
22. Zhao J, Wang J, Chen Y, Agarwal R. Anti-tumor-promoting activity of a polyphenolic fraction isolated from grape seeds in the mouse skin two-stage initiation-promotion protocol and identification of procyanidins B5-3′-gallate as the most effective antioxidant constituent. Carcinogenesis 1999; 20: 1737-1745.
23. Bagchi D, Garg A, Krohn RL, Bagchi M, Tran MX, Stohs SJ. Oxygen free radical scavenging abilities of vitamin C and E, and a grape seed proanthocyanidin extract in vitro. Res Commun Mol Pathol Pharmacol 1997; 95: 179-189.
24. Bagchi D, Garg A, Krohn RL, Bagchi M, Bagchi DJ, Balmoori J, Shohs SJ. Protective effects of grape seed proanthocyanidins and selected antioxidants against TPA-induced bepatic and brain lipid peroxidation and DNA fragmentation, and peritoneal macrophage activation in mice. Gen Pharmacol 1998; 30: 771-776.
25. Maffei FR, Carini M, Aldini G, Berti F, Rossoni G, Bombardelli E, Morazzoni P. Procyanidins from Vitis vinifera seeds protect rabbit heart from ischemia/reperfusion injury: antioxidant intervention and/or iron and copper sequestering ability. Planta Med 1996; 62: 495-502.
26. Yang CS, Hong J, Hou Z, Sang S. Free radicals: the pros and cons of antioxidants. Green tea polyphenols and prooxidative effects. J Nutr 2004; 134: 3181S.
27. Yang CS, Landau JM. Effects of tea consumption on nutrition and health. J Nutr 2000; 130: 2409-2412.
28. Yang CS, Maliakal P, Meng X. Inhibition of carcinogenesis by tea. Annu Rev Pharmacol Toxicol 2002; 42: 25-54.
29. Yang Y, Chien M. Characterization of grape procyanidins using high-performance liquid chromatography/mass spectrometry and matrix-assisted laser desorption/ionization time-of-flight mass spectrometry. J Agric Food Chem 2000; 48: 3990-3996.
30. Helms S. Cancer prevention and therapeutic: Panax ginseng. Altern Med Rev 2004; 9: 259-274.
31. Blumenthal M. Herb sales down 15 percent in mainstream market. Herbalgram 2001; 51: 69.
32. Draves AH, Walker SE. Analysis of the hypericin and pseudohypericin content of commercially available St. John's wort preparations. Can J Clin Pharmacol 2003; 10: 114-118.
33. Gurley BJ, Gardner SF, Hubbard MA. Content versus label claims in ephedra-containing dietary supplements. Am J Health Syst Pharm 2000; 57: 963-969.
34. Harkey MR, Henderson GL, Gershwin ME, Stern JS, Hackman RM. Variability in commercial ginseng products: an analysis of 25 preparations. Am J Clin Nutr 2001; 73: 1101-1106.
35. Zhang H, Coville PF, Walker RJ, Miners JO, Birkett DJ, Wanwimolruk S. Evidence for an involvement of human CYP3A in the 3-hydroxylation of quinine. Br J Clin Pharmacol 1997; 43: 245-252.
36. Wanwimolruk S, Wong SM, Zhang H, Coville PF. Simultaneous determination of quinine and a major metabolite 3-hydroxyquinine in biological fluids by HPLC without extraction. J Liq Chromatogr 1996; 19: 293-305.
37. Haller CA, Duan M, Benowitz NL, Jacob P 3rd. Concentrations of ephedra alkaloids and caffeine in commercial dietary supplements. J Anal Toxicol 2004; 28: 145-151.
38. Green GA, Catlin DH, Starcevic B. Analysis of over-the-counter dietary supplements. Clin J Sport Med 2001; 11: 254-259.
39. Hamburger M, Webner C, Benthin B. Cycloartane glycosides from Cimicifuga racemosa. Pharm Pharmacol Lett 2001; 11: 98-100.
40. Gurley BJ, Gardner SF, Hubbard MA, Williams DK, Gentry WB, Khan IA, Shah A. In vivo effects of golden seal, kava kava, black cohosh, and valerian on human cytochrome P450 1A2, 2D6, 2E1 and 3A4/5 phenotypes. Clin Pharmacol Ther 2005; 77: 415-426.
41. Gurley BJ, Gardner SF, Hubbard MA, Williams DK, Gentry WB, Cui Y, Ang CYW. Cytochrome P450 phenotypic ratios for predicting herb-drug interactions in humans. Clin Pharmacol Ther 2002; 72: 276-287.
42. Anderson GD, Rosito G, Mohustsy MA, Elmer GW. Drug interaction potential of soy extract and Panax ginseng. J Clin Pharmacol 2003; 43: 643-648.
43. Chow HH, Hakim IA, Vining DR, Crowell JA, Cordova CA, Chew WM, Xu MJ, Hsu CH, Ranger-Moore J, Alberts DS. Effects of repeated green tea catechin administration on human cytochrome P450 activity. Cancer Epidemiol Biomarkers Prev 2006; 15: 2473-2476.
44. Muto S, Fujita K, Yamazaki Y, Kamataki T. Inhibition by green tea catechins of metabolic activation of procarcinogens by human cytochrome P450. Mutat Res 2001; 479: 197-206.
45. Henning SM, Aronson W, Niu Y, Conde F, et al. Tea polyphenols and theaflavins are present in prostate tissue of humans and mice after green and black tea consumption. J Nutr 2006; 136: 1839-1843.
46. Cui J, Garle M, Eneroth P, Bjorkem I. What do commercial ginseng preparations contain? Lancet 1994; 344: 134.
47. Good Housekeeping Institute. New Good Housekeeping Institute study finds drastic discrepancy in potencies of popular herbal supplements. Consumer Safety Symposium on Dietary Supplements and Herbs, New York City, New York, March 3, 1998 (news release).
48. Foster BC, Arnason JT, Briggs CJ. Natural health products and drug disposition. Annu Rev Pharmacol Toxicol 2005; 45: 203-296.
49. Guengerich FP, Kim DH. In vitro inhibition of dihydropyridine oxidation and aflatoxin B1 activation in human liver microsomes by naringenin and other flavonoids. Carcinogenesis 1990; 11: 2275-2279.